Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Kenvue (NYSE: KVUE ) stock is in the news Monday after the company announced that Johnson & Johnson (NYSE: JNJ ) is selling its stake in the business. Kenvue has announced a secondary offering that
Dividend stocks from some of your favorite businesses can help boost your returns. J&J is benefitting from a vast portfolio of medicines and a resurgence in surgical procedures.

Kenvue Announces Launch of Secondary Offering

06:46am, Monday, 13'th May 2024
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue announced today the launch of a secondary underwritten public offering of 182,329,550 shares of its common stock.
It must be stated upfront that the concept of reliable dividend stocks isn't exciting. No, it's downright boring.
One of the most important things stock investors should look at is the fundamentals of a company. Each earnings season shows us how a compare fares and we get this idea through the fundamentals.
It may be tempting to step away from stocks for the summer. After a strong end to 2023, this was supposed to be a year when equities continued to rip higher.
The "Magnificent Seven" are largely responsible for sending the Dow Jones, S&P 500, and Nasdaq Composite to fresh all-time highs in 2024. However, electric-vehicle (EV) manufacturer Tesla has been far
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Shockwave Me
Johnson & Johnson increased its dividend payout earlier this year. The healthcare company has a stellar record of paying dividends.
Most investors are well aware that the S&P 500 was down 1.6% at the end of April. However, the ongoing earnings season and the promise of at least one rate cut later in the year have helped stocks kee
The stock market has performed well so far this year, with benchmark indices rising over 9%. After recovering from a dip in April, indices are nearing record highs set in March and could soon score ne
4 Dividend Aristocrats To Buy In May Plus 4 To Watch
Often overlooked, especially in times of AI revolution, the healthcare market is always a safe bet for investors, as it is a multiple trillion, highly innovative industry with no drawbacks like lack o
Johnson & Johnson is a steady portfolio stalwart. Abbott Labs has exciting growth opportunities ahead.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE